Core Viewpoint - Shanghai Laishi Blood Products Co., Ltd. announced the completion of a share buyback plan by certain directors and senior management, reflecting their confidence in the company's strategic development and long-term investment value [3][10]. Summary by Sections Share Buyback Plan - The company disclosed a plan for certain directors and senior management to increase their shareholdings starting from September 5, 2025, for a period of six months, with a minimum investment of RMB 6 million [3][10]. - The buyback was executed through centralized bidding, resulting in the acquisition of 946,000 shares, representing 0.014% of the total share capital, with a total expenditure of RMB 6.4828 million [10]. Participants in the Buyback - The buyback involved key executives including Jun Xu, Shen Jihui, Lu Hui, Liu Zheng, Song Zhengmin, Chen Leqi, and Huang Qinbing [3][10]. - Prior to the buyback, these executives held shares under the first employee stock ownership plan, with specific unblocked shares awaiting conditions for release [4]. Purpose and Conditions - The buyback aims to enhance investor confidence and is based on the executives' strong belief in the company's strategic direction [6][10]. - There is no set price range for the buyback; the executives will determine the timing based on their assessment of the stock's value [6][10]. Compliance and Regulations - The buyback adheres to relevant laws and regulations, ensuring that it does not affect the company's share distribution or control [10]. - The participating executives committed to not selling their shares during the lock-up period following the buyback [9][10].

Core Viewpoint - Shanghai Laishi (002252) announced that several executives, including the vice chairman and general manager Jun Xu, plan to increase their shareholding in the company, reflecting their confidence in the company's strategic development and long-term investment value [1] Group 1 - The executives plan to increase their shareholding by a total amount of no less than 6 million yuan within six months from the announcement date [1] - The funding for the share purchase will come from their own resources [1] - The decision to increase shareholding is aimed at enhancing investor confidence amid the current capital market conditions [1]